According to Charles River, it is the first contract research organization (CRO) to provide clients access to Apricot Designs' Dual Arm (ADDA) system in North America and Europe.
Designed for drug discovery, the system is a high-speed autosampler for liquid chromatography/mass spectrometry (LC/MS).
“Apricot Designs’ dual arm autosampler was designed with early discovery scientists in mind,” said Felix H. Yiu, founder and CEO, Apricot Designs, Inc. in a press release. “It enables seamless integration with LC/MS systems, accelerating the laboratory research process and yielding the best results.”
Charles River has also geographically expanded its pharmacokinetic (PK) capabilities in San Francisco and 's-Hertogenbosch, The Netherlands.
“The early discovery industry is seeing a marked shift towards a better understanding of the underlying biology of candidate compounds. Both HT-ADME and PK technologies are critical to that understanding, and to developing more successful candidates in early discovery,” explained Ian Waddell, PhD, executive director, biology, Charles River.